Trillium Asset Management LLC Has $3.02 Million Stock Position in Ingevity Co. (NYSE:NGVT)

Trillium Asset Management LLC lowered its position in shares of Ingevity Co. (NYSE:NGVT - Free Report) by 22.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 64,055 shares of the company's stock after selling 18,059 shares during the quarter. Trillium Asset Management LLC owned approximately 0.18% of Ingevity worth $3,024,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. GAMMA Investing LLC purchased a new stake in Ingevity in the fourth quarter valued at approximately $41,000. Principal Securities Inc. purchased a new stake in shares of Ingevity during the 4th quarter valued at $67,000. Quadrant Capital Group LLC increased its holdings in shares of Ingevity by 207.9% during the 4th quarter. Quadrant Capital Group LLC now owns 2,075 shares of the company's stock worth $98,000 after buying an additional 1,401 shares during the last quarter. Mackenzie Financial Corp purchased a new position in shares of Ingevity in the 4th quarter worth $208,000. Finally, Pathstone Family Office LLC boosted its holdings in Ingevity by 22.1% in the third quarter. Pathstone Family Office LLC now owns 4,430 shares of the company's stock valued at $211,000 after acquiring an additional 803 shares during the last quarter. 91.59% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

NGVT has been the topic of a number of research reports. BMO Capital Markets raised their price objective on Ingevity from $50.00 to $55.00 and gave the stock a "market perform" rating in a report on Wednesday, May 8th. Wells Fargo & Company lifted their price target on shares of Ingevity from $43.00 to $50.00 and gave the company an "equal weight" rating in a research report on Friday, February 23rd. Jefferies Financial Group raised shares of Ingevity from a "hold" rating to a "buy" rating and increased their price objective for the stock from $52.00 to $62.00 in a research report on Monday, April 22nd. Oppenheimer raised their target price on shares of Ingevity from $50.00 to $58.00 and gave the company an "outperform" rating in a research note on Thursday, May 2nd. Finally, Loop Capital upped their price target on shares of Ingevity from $49.00 to $56.00 and gave the stock a "hold" rating in a research report on Tuesday, May 7th. Five investment analysts have rated the stock with a hold rating and two have given a buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average price target of $55.00.

Ingevity Stock Down 2.7 %

Shares of NGVT stock traded down $1.50 on Friday, hitting $53.55. The stock had a trading volume of 234,671 shares, compared to its average volume of 234,051. Ingevity Co. has a 52-week low of $36.66 and a 52-week high of $66.18. The firm has a market capitalization of $1.95 billion, a price-to-earnings ratio of -17.22 and a beta of 1.79. The company has a debt-to-equity ratio of 2.48, a quick ratio of 0.98 and a current ratio of 1.90. The stock's 50 day moving average is $48.68 and its 200-day moving average is $45.21.

Ingevity (NYSE:NGVT - Get Free Report) last announced its earnings results on Wednesday, May 1st. The company reported $0.52 earnings per share for the quarter, beating the consensus estimate of $0.37 by $0.15. The company had revenue of $340.10 million during the quarter, compared to the consensus estimate of $319.15 million. Ingevity had a positive return on equity of 18.65% and a negative net margin of 6.84%. The company's revenue was down 13.4% on a year-over-year basis. During the same period last year, the firm earned $1.09 earnings per share. As a group, research analysts expect that Ingevity Co. will post 3.78 earnings per share for the current year.

Ingevity Profile

Ingevity Corporation manufactures and sells activated carbon products, derivative specialty chemicals, and engineered polymers in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. It operates through three segments: Performance Materials, Performance Chemicals, and Advanced Polymer Technologies.